Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
plasminogen activator, tissue type | 0.445 | 0.885 | 5.7E-05 |
|
disease | 0.400 | None | 0.978 | 45 | 0 | 1986 | 2019 | ||||||||
|
troponin I3, cardiac type | 0.520 | 0.769 | 9.6E-02 |
|
disease | 0.400 | None | 1.000 | 30 | 0 | 2001 | 2019 | ||||||||
|
interleukin 10 | 0.281 | 0.923 | 5.9E-03 |
|
disease | 0.500 | None | 0.923 | 26 | 0 | 2001 | 2019 | ||||||||
|
hepatocyte growth factor | 0.374 | 0.885 | 1.00 |
|
disease | 0.100 | None | 0.955 | 22 | 0 | 2000 | 2019 | ||||||||
|
gap junction protein alpha 1 | 0.393 | 0.885 | 0.16 |
|
disease | 0.300 | None | 0.950 | 20 | 0 | 2012 | 2019 | ||||||||
|
C-C motif chemokine ligand 2 | 0.321 | 0.962 | 0.61 |
|
disease | 0.300 | None | 0.842 | 19 | 0 | 2003 | 2019 | ||||||||
|
heme oxygenase 1 | 0.381 | 0.923 | 9.7E-03 |
|
disease | 0.300 | None | 1.000 | 18 | 0 | 2002 | 2019 | ||||||||
|
carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase | 0.482 | 0.846 | 1.00 |
|
disease | 0.100 | None | 0.824 | 17 | 0 | 1996 | 2019 | ||||||||
|
cytochrome P450 family 2 subfamily C member 19 | 0.467 | 0.846 | 6.5E-20 |
|
disease | 0.100 | None | 0.938 | 16 | 0 | 2009 | 2019 | ||||||||
|
microRNA 21 | 0.363 | 0.846 |
|
disease | 0.100 | None | 1.000 | 16 | 0 | 2011 | 2019 | |||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha | 0.292 | 0.923 | 1.00 |
|
disease | 0.100 | None | 0.938 | 16 | 0 | 2006 | 2020 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma | 0.320 | 0.885 | 1.4E-06 |
|
disease | 0.100 | None | 0.938 | 16 | 0 | 2006 | 2020 | ||||||||
|
phospholipase A2 group IIA | 0.488 | 0.808 | 9.7E-02 |
|
disease | 0.100 | None | 0.625 | 16 | 0 | 1997 | 2014 | ||||||||
|
chromosome 20 open reading frame 181 | 0.479 | 0.885 |
|
disease | 0.100 | None | 0.933 | 15 | 0 | 1996 | 2019 | |||||||||
|
natriuretic peptide B | 0.513 | 0.808 | 9.9E-06 |
|
disease | 0.300 | None | 1.000 | 15 | 0 | 2001 | 2019 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta | 0.322 | 0.885 | 1.00 |
|
disease | 0.100 | None | 0.933 | 15 | 0 | 2006 | 2020 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta | 0.319 | 0.885 | 1.00 |
|
disease | 0.100 | None | 0.933 | 15 | 0 | 2006 | 2020 | ||||||||
|
solute carrier family 5 member 2 | 0.499 | 0.769 | 4.9E-14 |
|
disease | 0.100 | None | 1.000 | 15 | 0 | 2017 | 2020 | ||||||||
|
high mobility group box 1 | 0.368 | 0.923 | 0.82 |
|
disease | 0.600 | None | 0.929 | 14 | 0 | 2011 | 2019 | ||||||||
|
myeloperoxidase | 0.377 | 0.923 | 7.1E-15 |
|
disease | 0.100 | None | 0.929 | 14 | 0 | 2003 | 2019 | ||||||||
|
serpin family A member 5 | 0.507 | 0.808 | 6.2E-09 |
|
disease | 0.100 | None | 0.929 | 14 | 0 | 2017 | 2020 | ||||||||
|
signal transducer and activator of transcription 3 | 0.320 | 0.923 | 1.00 |
|
disease | 0.100 | None | 1.000 | 14 | 0 | 2010 | 2019 | ||||||||
|
caspase 3 | 0.351 | 0.923 | 0.10 |
|
disease | 0.600 | None | 1.000 | 14 | 0 | 2002 | 2019 | ||||||||
|
cellular communication network factor 2 | 0.399 | 0.846 | 5.0E-04 |
|
disease | 0.300 | None | 1.000 | 13 | 0 | 2000 | 2019 | ||||||||
|
endothelin 1 | 0.380 | 0.846 | 0.46 |
|
disease | 0.300 | None | 1.000 | 13 | 0 | 1999 | 2019 |